Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) Stock Information | RedChip

Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) Listen to this Section


$13.43
-0.5300 ( -3.80% ) 746.8K

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.

Market Data


Insider Ownership Transactions

Total Amount Purchased: -4,461,747.00 | $ -59,921,262.21

Date Type Amount Purchased Purchaser
2024-01-26 Buy 280000.00 Puhlmann Markus
2023-12-26 Buy 3663.00 Williamson Robert F III
2023-12-19 Buy 10000.00 Williamson Robert F III
2023-12-19 Buy 135006.00 Puhlmann Markus
2023-12-19 Buy 125000.00 Hunt Jonathan Robert
2023-12-18 Buy 32238.00 Woods Lori A
2023-12-14 Sale -230000.00 Williamson Robert F III
2023-12-14 Sale -1248776.00 Hunt Jonathan Robert
2023-12-14 Sale -230000.00 Morich Frank
2023-12-14 Sale -3338878.00 Spoor Johan M.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 03, 2024
8-k 8K-related 12 May 31, 2024
4 Insider transactions 1 May 30, 2024
8-k 8K-related 17 May 29, 2024
8-k 8K-related 13 May 20, 2024
10-q Quarterly Reports 75 May 15, 2024
8-k 8K-related 13 May 15, 2024
4 Insider transactions 1 Apr 24, 2024
def Proxies and info statements 5 Apr 18, 2024
8-k 8K-related 12 Apr 16, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.